BML Capital Management LLC Acquires 2,186,587 Shares of Seer, Inc. $SEER

BML Capital Management LLC bought a new stake in Seer, Inc. (NASDAQ:SEER) during the 3rd quarter, HoldingsChannel reports. The firm bought 2,186,587 shares of the company’s stock, valued at approximately $4,876,000. Seer accounts for 2.6% of BML Capital Management LLC’s investment portfolio, making the stock its 10th biggest holding.

A number of other institutional investors and hedge funds have also modified their holdings of SEER. Covestor Ltd purchased a new stake in shares of Seer during the third quarter worth about $109,000. Marquette Asset Management LLC acquired a new position in shares of Seer during the 2nd quarter worth about $103,000. Corient Private Wealth LP lifted its stake in Seer by 15.8% in the 2nd quarter. Corient Private Wealth LP now owns 73,200 shares of the company’s stock valued at $122,000 after buying an additional 10,000 shares in the last quarter. NewEdge Advisors LLC purchased a new position in Seer in the 1st quarter valued at about $132,000. Finally, Rangeley Capital LLC lifted its stake in Seer by 821.5% in the 1st quarter. Rangeley Capital LLC now owns 184,302 shares of the company’s stock valued at $310,000 after buying an additional 164,302 shares in the last quarter. Hedge funds and other institutional investors own 75.20% of the company’s stock.

Seer Stock Performance

Shares of Seer stock opened at $1.57 on Friday. Seer, Inc. has a one year low of $1.53 and a one year high of $2.38. The company has a market cap of $86.93 million, a price-to-earnings ratio of -1.37 and a beta of 1.49. The business’s 50 day moving average price is $1.94 and its 200 day moving average price is $1.91.

Seer (NASDAQ:SEER) last released its quarterly earnings data on Tuesday, November 10th. The company reported ($0.25) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.26) by $0.01. The company had revenue of $3.98 million for the quarter, compared to analyst estimates of $4.15 million. Seer had a negative return on equity of 27.03% and a negative net margin of 450.86%.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Seer in a report on Thursday, October 15th. Two equities research analysts have rated the stock with a Strong Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $4.00.

Seer Profile

Seer, Inc. is a life sciences company that develops tools for large-scale protein analysis, or proteomics. Founded in 2017 and based in Redwood City, California, the company serves researchers studying biology and disease. Its main offering, the Proteograph Product Suite, uses engineered nanoparticles to capture a broad range of proteins from biological samples. The suite combines nanoparticle reagents, consumables, automation and software with mass spectrometry workflows to help researchers analyze complex samples.